⊙ Reporter edit 0 Xiaohua Wang Ruan Qi Huan road in early April, Societe Generale securities, guosen securities have published 2 quarters and pharmaceutical investment strategy report for April. Among them, without exception, seen a lot of medical devices section. At the same time, since the first quarter of this year, the Fund attitude has the experience of the pharmaceutical unit early after a wave of mass reduction of had been optimistic fund managers start backhand long, "latent" medicine plate broken down some of the industry, look forward to them again in the second half with. Recommended reading · 2011 2nd quarter Fund NET estimates
· Xia stage fengji investment policy fund second quarter continues to see more Fund "latent" medical instruments industry leading Wang yawei latent 7 only brokerages unit (schedule) second quarter layout unit base institutions four policy zhizhao Qian private a brother William l. Rowe wide heavy warehouse unit exposure acting April market private "tight cover" cycle unit [hexun know] found Investment Fund started books can said, in valuation increasingly reasonable and market expansion, and export to good of large background Xia, medical instruments plate became investment territories most favored of area one.
Industry experts agree that 2011 is investing the medical device industry leading golden age, including diving medical (002223, unit), nine elderly medical (002432, unit), medical, medical, Wan Dong medical treatment, Xinhua Yang Pu medical and other listed companies are expected to benefit. birth is expected to a world-class enterprise industry experts said the new round of national health reform focus on supporting the rural medical institution-building, including the new township, increased investment in county hospitals, such as improving public health services in rural areas. And there are more than more than 80,000 County Hospital and township. Therefore, medical device companies face a huge market opportunity.
China medical device company has strong market development and technology research and development, through mergers and acquisitions further enrich the product line, is expected in the next round of competition was born a world-class enterprise. "I believe that, within the next 5 years, billions of the birth of China will certainly scale sales of medical equipment company.
"Diving medical Chairman and General Manager Wu Guangming very optimistic. In 2008, diving medical only 31 million profit at the beginning of the listing, but three years later, the company has maintained high growth, 50% performance and profit growth per year with admiration throughout the industry. Kuang-ming Wu told reporters that currently do 2012 year of market layout. 300 acres of new plants in accordance with the scale of the 5 billion to design productivity. And medical appliances is another development priorities for the future.
In addition, the company also will seek, through extension of mergers and acquisitions to promotion of access to technology and products. MINDRAY medical is acquisition of United States companies and listed on the New York Stock Exchange, to the internationalization of enterprises towards the target of a significant step forward.
Xuhang, Chairman of the company has said that will accelerate over the coming years to expand international market share, and strive to become the world's industry leaders at an early date.
In the view of investment institutions Monita, in a variety of market segments, there are many attractive investment opportunities for medical devices industry. deep digging "healthcare directory" and niche market market large companies.
In fact, it's just this individual a huge market in China will provide one of the many excellent opportunities to local companies. According to informed sources, some Chinese medical device companies are expected to breakthrough progress in health insurance directory in advance. "Some enterprises in Jiangsu and other provinces have made a breakthrough, if access to health insurance directory, will lead to 5-8 the sales growth, such as cochlear medical assistive products. "Think globally, in the United States, and Japan and other mature markets, medical devices are in the health insurance directory.
And China's medical device companies are eagerly awaited an early taste of "healthcare directory" this big cake.
In addition, the medical device market segment is dig deep. According to CCID consulting Helen Qiao is expected, portable medical electronics market in China will enter a phase of high growth.
Electronic thermometers, sphygmomanometers, portable medical devices such as blood glucose meter, disease monitoring systems will be driven by a round of important engine of growth in medical device market. Great potential of the Chinese market is more than that.
Perennial engaged in the development of medical market of Singapore, Deputy General Manager Liang zhiwu benevolence medical service said added 30,000 of hearing loss in children each year, 20,000 people can restore hearing by cochlear implant, which had hearing loss has been 27.8 million population base in China, of which, 7.4 million people for cochlear implant restoration hearing, there is market potential is also very large. At present, the Shanghai acoustic cochlear implant made of special medical technology national medical device registration certificate issued by the food and drug administration, and has been listed company cochlear device certificate Hainan drug (000566, unit) are trying to issue new shares. Securities analysts believe that, after the issuance of equity 51% Hainan drug will account for powerful sound, became the controlling shareholders. Complete issuance of cochlear project not only makes it put into production and sales, is expected to force extra-cochlear (adult treatment) in the second half of 2011 and commissioned sales, after 3 years of market cultivation, to around 2014, its annual sales could hit 10,000 units, sales income of about $ 340 million and profit of 100 million Yuan.